California Public Employees Retirement System Inozyme Pharma, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$15.19 - $21.2 $218,736 - $305,280	-14,400 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$17.77 - $27.9 $23,296 - $36,576	-1,311 Reduced 8.34%	14,400 $285,000
Q4 2020 Feb 02, 2021	SELL	$19.95 - $27.55 $5,985 - $8,265	-300 Reduced 1.87%	15,711 $324,000
Q3 2020 Nov 05, 2020	BUY	$17.54 - $30.2 $280,832 - $483,532	16,011 New	16,011 $421,000

Others Institutions Holding INZY

# of Institutions

Shares Held

53.3M

Call Options Held

3.7K

Put Options Held

5.8K

Adage Capital Partners Gp, L.L.C. Boston, MA

5.67M
Shares

$8.51 Million
0.05% of portfolio
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA

4.49M
Shares

$6.74 Million
18.53% of portfolio
Sofinnova Investments, Inc. Menlo Park, CA

4.28M
Shares

$6.42 Million
2.12% of portfolio
Eventide Asset Management, LLC Boston, MA

4.13M
Shares

$6.2 Million
0.38% of portfolio
Rock Springs Capital Management LP Baltimore, MD

3.8M
Shares

$5.7 Million
0.68% of portfolio

View Full List

About Inozyme Pharma, Inc.

Ticker INZY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,145,700
Market Cap $60.2M
Description
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...

More about INZY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account